BioSpace News Archive

Drug Development

Flexion Therapeutics Highlights Two Clinical Data Presentations at the 2017 American College of Rheumatology Annual Meeting

Zilretta is a non-opioid medicine that employs Flexion’s proprietary microsphere technology.

November 3, 2017
·
10 min read
Business

IRIDEX Announces 2017 Third Quarter Financial Results

The company reported record third quarter revenue of $10.9 million, an 11% year-over-year increase.

November 3, 2017
·
6 min read
Business

SeaSpine Reports Third Quarter 2017 Financial Results

The company reported revenue of $31.7 million, unchanged compared to the prior year.

November 3, 2017
·
8 min read
Business

MyoKardia Reports Third Quarter 2017 Financial Results and Operational Progress

MyoKardia also provided an update on the company’s End-of-Phase 2 meeting with the U.S. Food and Drug Administration’s (FDA) Division of Cardiovascular and Renal Products.

November 3, 2017
·
14 min read
Drug Development

VetDC Announces New TANOVEA-CA1 Publication and State of the Art Presentation at the Veterinary Cancer Society 2017 Annual Conference

TANOVEA-CA1 has demonstrated anti-tumor activity in both naïve and relapsed canine lymphoma cases, with a generally well-tolerated safety profile.

November 3, 2017
·
2 min read
Drug Development

ACADIA Pharmaceuticals Presents Data From the Phase II Study of Pimavanserin in Alzheimer’s Disease Psychosis at the Clinical Trials on Alzheimer’s Disease (CTAD) 2017 Meeting

Pimavanserin met the primary endpoint in the Phase II -019 Study, showing a statistically significant reduction in psychosis versus placebo, as previously reported.

November 3, 2017
·
12 min read
Business

ImmuCell to Announce Financial Results for Third Quarter of 2017

The Company has scheduled a conference call that same day, Monday, November 13, 2017, at 4:30 PM ET to review the results.

November 3, 2017
·
4 min read
Business

Accelerate Diagnostics Reports Q3 2017 Financial Results

The company further reported signed agreements for 295 instruments year to date.

November 3, 2017
·
9 min read
Business

Voyager Therapeutics Reports Third Quarter 2017 Financial Results and Corporate Highlights

The company will host a conference call and webcast today at 4:30 p.m. EDT to discuss these results.

November 3, 2017
·
18 min read
Business

Pacific Biosciences of California Announces Third Quarter 2017 Financial Results

Product, service and other revenue for the third quarter of 2017 increased by 9% to $23.5 million, compared to $21.5 million for the third quarter of 2016.

November 3, 2017
·
5 min read